Effect of goniothalamin on the development of Ehrlich solid tumor in mice

Bioorg Med Chem. 2010 Sep 15;18(18):6742-7. doi: 10.1016/j.bmc.2010.07.053. Epub 2010 Jul 27.

Abstract

In this work the antiproliferative activity of goniothalamin (1), both in racemic and in its enantiomeric pure forms, in a solid tumor experimental model using laboratory animals is described. The antiedematogenic activity displayed by racemic 1 in the carrageenan edema model in mice together with the reduction of Ehrlich solid tumor model suggest a relationship between anticancer and antiinflammatory activities with the antiinflammatory activity favoring the antiproliferative activity itself.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / chemistry
  • Anti-Inflammatory Agents / therapeutic use*
  • Anti-Inflammatory Agents / toxicity
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Agents / toxicity
  • Carcinoma, Ehrlich Tumor / drug therapy*
  • Carrageenan / toxicity
  • Cell Line, Tumor
  • Disease Models, Animal
  • Edema / chemically induced
  • Edema / drug therapy
  • Humans
  • Mice
  • Pyrones / chemistry
  • Pyrones / therapeutic use*
  • Pyrones / toxicity
  • Stereoisomerism

Substances

  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Pyrones
  • goniothalamin
  • Carrageenan